Bill Ackman

Bill Ackman

Last Update: 03-14-2017

Number of Stocks: 8
Number of New Stocks: 0

Total Value: $5,913 Mil
Q/Q Turnover: 15%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Bill Ackman Watch

  • 9 Stocks Mario Gabelli Continues to Buy

    Mario Gabelli (Trades, Portfolio) is the founder, chairman and CEO of Gabelli Asset Management Co. Investors (GAMCO Investors) a $30 billion global investment firm headquartered in Rye, New York. He manages a portfolio composed of 816 stocks with a total value of $15.827 billion. In the third and fourth quarters of 2016 the guru bought shares in the following stocks:


    Platform Specialty Products Corp. (PHA)

      


  • Bill Ackman Vs. Herbalife Documentary Opens in Theaters March 17

    The Wall Street movie documenting Bill Ackman (Trades, Portfolio)'s crusade against multi-level marketing company Herbalife (NYSE:HLF) and Carl Icahn (Trades, Portfolio)'s opposing position has been making its way around film festivals and opens in theaters Friday, March 17.


    Writer and director Ted Braun explores whether or not Herbalife is a pyramid scheme exploiting its members and not delivering the income it promises them as Ackman has said. Ackman, the manager of hedge fund Pershing Square, has spent considerable effort to expose the company, but also stands to make billions if it fails.

      


  • Did Ackman Make the Right Decision to Sell Valeant?

    Bill Ackman (Trades, Portfolio)'s decision to sell his long-standing stake in Valeant Pharmaceuticals (NYSE:VRX) has attracted plenty of attention over the past week. His decision to throw in the towel may have come as a surprise to many considering his previous comments, and it is fair to say he has attracted lots of criticism both while in the position and after exiting.


    It is hard not to feel at least a bit sorry for this former rock star hedge fund manager as he faced the same problem most investors will have to face at least once in their career: when to sell a loser.

      


  • Oakmark: The Psychology of Ownership and Investing

    Lauren Harvey is a product specialist across all of the firm’s investment strategies. Before joining Harris Associates in 2016, Lauren spent nine years at UBS Asset Management, most recently as a fundamental, value-oriented equity specialist. Prior to UBS, she worked in financial reporting at a Chicago-based bank holding company. Lauren has an MBA from the University of Chicago Booth School of Business (2011) and completed her undergraduate studies at Southern Methodist University (2005).


    Through his pioneering work with children, famed psychologist Jean Piaget uncovered a profound truth about human nature: Our sense of ownership develops extraordinarily early. But why do we feel such inherent attachment to things? A brief exploration of the psychology of ownership helps answer this question and gives us confidence in the investment approach we take at the Oakmark Funds.

      


  • Bill Ackman Has Had Enough Precipitous Declines for One Stock, Sells Valeant

    After preparing everyone for a different sell by filing a prospectus to unload Chipotle (NYSE:CMG) last week, Bill Ackman (Trades, Portfolio) exited his entire stake in Valeant Pharmaceuticals (NYSE:VRX), a stock that has haunted his returns and contributed to the worst year in his fund’s history.


    Ackman is selling his 7.26% stake of 18,114,432 shares of Valeant for around $11.04, their high Tuesday, before the price plunged 10.07% to $10.89 to close after his public filing was released. The price represents an almost 96% drop from the stock’s July 2015 high.

      


  • New Feature Announcement: The User Manuals

    As we ring in March 2017, we are pleased to announce a new feature on GuruFocus, the User Manuals. Like cooking recipes, these user manuals give detailed instructions on how to use our most popular features on the website.


    Throughout the past few years, GuruFocus introduced several new features for our Premium and Premium Plus members, including customized series in Interactive Charts, custom filters and screeners, backtesting, the DCF Fair Value Calculator, personalized guru lists, the All-in-one Guru Screener and backtesting, My Portfolios, GuruFocus in Excel and the Application Programming Interface (API). This article will briefly discuss each of the above features and give links to the respective user manuals.

      


  • Valeant Pharmaceuticals Is a Potential Sell

    Valeant Pharmaceuticals Inc. (NYSE:VRX) reported a net loss of $515 million during fourth-quarter 2016 based on generally accepted accounting principles and an adjusted EBITDA of $1.05 billion. For full-year 2016, the company reported a GAAP net loss of $2.4 billion, which translates to a loss per share of approximately $6.94. These values suggest that Valeant has a weakening financial outlook for 2017.


    Brief summary of earnings report

      


  • Big Money Still Long Valeant

    Valeant Pharmaceuticals International Inc. (NYSE:VRX) reported a better-than-expected quarterly profit this morning as a result of lowered costs and strength in its Bausch and Lomb subsidiary, yet its net loss widened as the company is feeling pricing pressure.


    Valeant has lost a lot of trust in the last two years. This is an understatement since in just 24 months, the stock has dropped over 90% from its highs in the 200 range. It has taken a lot of hedge funds with it, but the roster of gurus that own Valeant remains impressive.

      


  • This Guru Loves Valeant; Should You?

    Hedge funds’ final 13F forms for 2016 were published last week, and as usual, the data has been scrutinized by the financial media. There were a few surprises in the figures, including Warren Buffett (TradesPortfolio)'s new favorite position, Apple (NASDAQ:AAPL), and the general rotation away from tech toward financials.


    One position change that stands out, however, is not Buffett’s move but that of Francis Chou (Trades, Portfolio). Chou’s Chou Associates is a traditional value fund, and Chou is well known in the value community for his investing style.

      


  • Francis Chou Adds to Valeant, Trims Sears in 4th Quarter

    Francis Chou (Trades, Portfolio), founder of Chou Associates Management, started an investment club in 1981 with six of his fellow telephone repairman. Throughout the next five years, Chou worked as a retail analyst at GW Asset Management where he met “Canadian Warren Buffett (Trades, Portfolio)” Prem Watsa (Trades, Portfolio). The successful guru established his flagship fund, the Chou Associate Fund, in 1986. On an annual basis, Chou’s fund outperformed the Standard & Poor’s 500 index benchmark by approximately 7% on average from 1986 to 2010.


    Chou invests in companies with a value-oriented approach involving a detailed analysis of the strengths of companies, especially in regard to the balance sheet, cash flow characteristics, profitability, industry position, special strengths, future growth potential and management ability. During fourth-quarter 2016, the Chou Associates Fund manager expanded his position in Valeant Pharmaceuticals International Inc. (NYSE:VRX) and trimmed his position in Sears Holdings Inc. (NASDAQ:SHLD).

      


  • Bill Ackman Expands Chipotle Position, Cuts Zoetis

    Activist investor Bill Ackman (Trades, Portfolio), founder of Pershing Square Capital Management, buys the common stock of companies and pushes for changes so that the market can realize the values of these companies. Like fellow activist investor Carl Icahn (Trades, Portfolio), Ackman buys out-of-favor companies at a discount and sells them when the companies reach their appraised value.


    During fourth-quarter 2016, Ackman purchased additional shares in Chipotle Mexican Grill Inc. (NYSE:CMG) and eliminated his stake in Zoetis Inc. (NYSE:ZTS). The investor also trimmed his position in three companies: Valeant Pharmaceuticals International Inc. (NYSE:VRX), Platform Specialty Products Corp. (NYSE:PAH) and Air Products & Chemicals Inc. (NYSE:APD).

      


  • Is Value Investing Dead?

    Value investing has changed significantly since the concept was conceived by Benjamin Graham more than 80 years ago. Today it’s tough to adopt the same style as Graham. The prevalence of financial information and stock screeners online has reduced the number of opportunities available, and investors have to be quick to take advantage of any market dislocations.


    Value investing has changed

      


  • Ackman, Berkowitz May Not Get Their Fannie Mae Payout So Fast Under Trump

    Bill Ackman (Trades, Portfolio), who has sued to release Fannie Mae (FNMA) and Freddie Mac (FMCC) from government conservatorship, said this week he has increased confidence that the Trump administration would ensure and hasten the reform of the government-sponsored entities, a move that would further enrich him and a number of his hedge and mutual fund peers.


    Ackman has wagered roughly 9% of his hedge fund’s assets that the government would return the two entities, which it rescued from collapse in the 2008 mortgage crisis, to private ownership and end its confiscation of their profits. He, along with several other large stakeholders such as Bruce Berkowitz (Trades, Portfolio) of Fairholme Fund (Trades, Portfolio), have already made sizable gains on their bets, as the market hopes for an imminent and profitable decision on the lenders’ fate. Shares of Fannie Mae that traded for under 30 cents in 2013 have already surged 150% since the election.

      


  • 10 Questions With Value Investor T. Aaron Brown

    1. How and why did you get started investing? What is your background?


    I have a scenic tour background. Many turns. I was a math teacher and then a youth counselor before I started working in government. I have held agent positions with both state and federal departments. I started investing a few years out of college with a series of trial by error. My primary editor is Seeking Alpha. I like the community as it provides a lot of feedback.

      


  • Chipotle Could Be a 4-Bagger in 10 Years

    Chipotle Mexican Grill (NYSE:CMG) has been among the most successful fast food chains in recent years by providing differentiated high quality food served quickly in a good environment.


    The company claims that it uses naturally grown ingredients and serves more naturally raised meat than any other restaurant chain. Customers liked it. The number of stores grew from over 500 locations in 2006 to about 2,200 locations. But the company suffered significantly starting in November 2015 when E. coli outbreaks were linked directly to its restaurants. Comparable sales were in the negative 20%-plus range in 2016. Earnings dropped to close to zero.

      


  • US Retailers May Look Valuable, but Watch the Trap

    After some poor holiday trading updates, investors have fled the U.S. retail sector in droves in the past few weeks extending the exodus from retail stocks that has been ongoing for around six months.


    For contrarian investors, this exodus has thrown up an interesting opportunity. Shares in retailers such as JCPenney Co. Inc. (NYSE:JCP), Kohl's Corp. (NYSE:KSS), Dillard’s Inc. (NYSE:DDS), Macy’s Inc. (NYSE:M), Sears Holdings Corp. (NASDAQ:SHLD) and Nordstrom Inc. (NYSE:JWN) have fallen to 52-week lows and are now trading at relatively appealing valuations.

      


  • 3 Rules for Successfully Investing Alongside Activists

    Investing alongside activist investors can be a tantalizing proposition. There are few outright bargains in the market now and a company that is trading cheaply with a definite catalyst in an activist investor gaining control can be very appealing. We have invested alongside activists several times over the years. We have had our successes and failures, so we want to share three rules we have developed over time that we believe increase the odds of an investment alongside an activist being a success.


    1. Try to buy at a similar price as the activist

      


  • 23 Questions With Value Investor Ari M. Eden

    1. How and why did you get started investing? What is your background?


    I was exposed to it a bit as a kid with some family members who were pretty big market followers, but I really didn't get into it for myself until finishing college and realizing I better learn to supplement income. After graduation I interned at a discount brokerage and then began learning all I could about the markets.

      


  • Technology Companies Among Strong Guru Ownership Stocks

    While all investment gurus seek long-term capital appreciation, not all gurus think identically. Some gurus invest in companies with a fundamental, value-oriented approach while other gurus, like Bill Ackman (Trades, Portfolio) and Carl Icahn (Trades, Portfolio), actively invest in distressed companies and generate value through company reforms. However, regardless of their investing approach, gurus usually invest in companies that offer high value potential to their fund and shareholders.


    In Part 1, we analyzed the Aggregated Portfolio of Gurus, which lists the 50 companies with the highest combined weighting among the gurus selected through the “Personalized List” feature.

      


  • Bill Ackman Reduces Valeant Stake to Benefit Clients

    As another tumultuous year has wiped out nearly 85% of Valeant Pharmaceuticals’ market value, Bill Ackman (Trades, Portfolio), one of its biggest investors, sold some shares to give his clients a year-end tax break.


    Ackman’s Pershing Square hedge fund initiated its Valeant (NYSE:VRX) position in early 2015 during the drugmaker’s heyday north of $177 per share, before its price went into freefall beginning in July that year. In the first quarter 2016, Ackman responded by purchasing 5 million additional shares, but Valeant’s further drop has resulted in a total estimated loss of 81% on the stake, a blow to returns at his fund.

      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)